Global In-Vitro Fertilization Market, 2024 - Opportunities in Increased Fertility Tourism
DUBLIN, Nov. 5, 2018 /PRNewswire/ --
The "Global In Vitro Fertilization Market" report has been added to ResearchAndMarkets.com's offering.
The global in vitro fertilization market is estimated to witness a CAGR of 11.2% during the forecast period 2018-2024. The global market is analyzed based on four segments - products, cycle types, end-users, and regions.
The in vitro fertilization market is driven by increasing awareness among the public about fertility and accessible treatment options, delayed pregnancies, reducing fertility rates, and initiation from the government to promote IVF treatment. However, high treatment cost, ethical concerns related to IVF, and low success rate of the procedure may slow down the growth of the in vitro fertilization market.
Regional Analysis:
The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). Europe is the major shareholder in the global in vitro fertilization market, followed by North America. Increasing demand for assisted reproductive technology procedures and smooth implementation of advanced technology make Europe a dominant shareholder in the market. Whereas, Asia Pacific is the fastest growing market due to increasing fertility tourism, upsurge in awareness, and acceptance of the technology.
Product Analysis:
The in vitro fertilization market, by products, is segmented into reagents and instruments. Reagents include embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. Instruments comprise imaging system, sperm separation system, ovum aspiration pump, micromanipulator system, incubators, cryosystems, and others. The instruments segment occupied a significant market share in 2017 and is expected to grow at a high CAGR during the forecast period.
Cycle Type Analysis:
The in vitro fertilization market, by cycle type, is segmented into fresh IVF cycles (non-donor), thawed IVF cycles (non-donor), and donor IVF cycles. Fresh IVF cycles segment occupied a significant market share in 2017 and is expected to grow at a high CAGR during the forecast period due to the increased success rate in the first attempt.
End-users Analysis:
The in vitro fertilization market, by end-users, is segmented into hospitals and research laboratories, fertility and surgical centers, and cryobanks. Fertility and surgical centers segment occupied a significant market share in 2017 and is expected to remain the same for the next five years due to the availability of technologically advanced IVF treatment and a broad range of fertility treatment with reimbursement facilities.
Key Players:
Thermo Fisher Scientific, Inc., Vitrolife, Cook Medical Inc., Cooper Companies (CopperSurgical Inc.), Irvine Scientific, Genea Limited, OvaScience Inc., Hunter Scientific, EMD Sereno, Inc., ESCO Micro Pte Ltd., and niche players.
Competitive Analysis:
There is an increase in acquisition, collaboration between IVF-related companies, and launching of new IVF products due to the favorable environment for IVF across the globe. For instance, in August 2018, Ferring Pharmaceuticals and Celmatix announced a collaboration, and the primary goal is to uncover new insights into ovarian biology and to accelerate the development of personalized interventions in women health and reproductive medicine. In August 2018, Thomson Medical announced to extend IVF services to China, in collaboration with assisted reproduction specialist IVI-RMA.
Key Topics Covered:
1 Industry Outlook
1.1 Industry Overview
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition - Research
3.2 Advantages Of In Vitro Fertilization
3.3 Disadvantage Of In Vitro Fertilization
3.4 Need Of In Vitro Fertilization
3.5 Process Of In Vitro Fertilization
3.6 Segmented Addressable Market (Sam)
3.7 Trends Of The In Vitro Fertilization Market
3.8 Related Markets
3.8.1 Female Condom Market
3.8.2 Erectile Dysfunction Market
4 Market Outlook
4.1 History Of In Vitro Fertilization
4.2 Market Segmentation
4.3 Pest Analysis
4.4 Porter 5(Five) Forces
5 Market Characteristics
5.1 Dro - Global In Vitro Fertilization Market Dynamics
5.1.1 Drivers
5.1.1.1 Reducing Fertility Rates
5.1.1.2 Deferred Pregnancies Among Women
5.1.2 Opportunities
5.1.2.1 Initiation From The Government To Promote Ivf Treatment
5.1.2.2 Increased Fertility Tourism
5.1.3 Restraints
5.1.3.1 High Cost Of Ivf Treatment
5.1.3.2 Low Success Rate Of Ivf Treatment
5.2 Dro - Impact Analysis
5.3 Key Stakeholders
6 Products: Market Size And Analysis
6.1 Overview
6.2 By Reagents
6.2.1 Cryopreservation Media
6.2.2 Sperm Processing Media
6.2.3 Embryo Culture Media
6.2.4 Ovum Processing Media
6.3 By Instruments
6.3.1 Imaging System
6.3.2 Ovum Aspiration Pumps
6.3.3 Sperm Separation Systems
6.3.4 Micromanipulator Systems
6.3.5 Incubators
6.3.6 Cryosystems
6.3.7 Others
7 By Cycle Type: Market Size And Analysis
7.1 Overview
7.2 Fresh Ivf Cycle (Non-Donor)
7.3 Thawed Ivf Cycle (Non-Donor)
7.4 Donor Egg Ivf Cycles
8 By End-Users: Market Size And Analysis
8.1 Overview
8.2 Hospitals And Research Laboratories
8.3 Fertility And Surgical Centers
8.4 Cryobanks
9 Regions: Market Size And Analysis
10 Competitive Landscape
11 Vendor Profiles
- Thermo Fisher Scientific, Inc.
- Vitrolife
- Cook Medical Inc.
- Cooper Companies (Coopersurgical Inc.)
- Irvine Scientific
12 Companies To Watch For
- Genea Limited
- Emd Sereno, Inc.
- Esco Micro Pte Ltd
- Hunter Scientific
- Ovascience Inc
- Oxford Gene Technology
For more information about this report visit https://www.researchandmarkets.com/research/wlp47t/global_invitro?w=5
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article